ALDH7A1 and metabolic dysfunction-associated steatotic liver disease: Isoforms like PDE3 and PDE4 are significantly associated with lipid metabolism [166], and the inhibition of PDE activity by PDE inhibitors has been shown to attenuate MASLD.